Anna Tesei Biosciences Laboratory Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Biography Publications Institution JoVE Articles Anna Tesei has not added a biography. If you are Anna Tesei and would like to personalize this page please email our Author Liaison for assistance. Publications DNA Ploidy and S-phase Fraction Analysis in Peritoneal Carcinomatosis from Ovarian Cancer: Correlation with Clinical Pathological Factors and Response to Chemotherapy OncoTargets and Therapy. 2017 | Pubmed ID: 29033584 Preclinical Evidence of Multiple Mechanisms Underlying Trastuzumab Resistance in Gastric Cancer Oncotarget. Apr, 2016 | Pubmed ID: 26919099 3D Tumor Spheroid Models for in Vitro Therapeutic Screening: a Systematic Approach to Enhance the Biological Relevance of Data Obtained Scientific Reports. Jan, 2016 | Pubmed ID: 26752500 Cancer Multicellular Spheroids: Volume Assessment from a Single 2D Projection Computer Methods and Programs in Biomedicine. Feb, 2015 | Pubmed ID: 25561413 Improving Reliability of Live/dead Cell Counting Through Automated Image Mosaicing Computer Methods and Programs in Biomedicine. Dec, 2014 | Pubmed ID: 25438936 Anti-tumor Activity of Fenretinide Complexed with Human Serum Albumin in Lung Cancer Xenograft Mouse Model Oncotarget. Jul, 2014 | Pubmed ID: 25015569 In Vitro Irradiation System for Radiobiological Experiments Radiation Oncology (London, England). Nov, 2013 | Pubmed ID: 24180359 Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models PloS One. 2013 | Pubmed ID: 23667504 Organosulfur Derivatives of the HDAC Inhibitor Valproic Acid Sensitize Human Lung Cancer Cell Lines to Apoptosis and to Cisplatin Cytotoxicity Journal of Cellular Physiology. Oct, 2012 | Pubmed ID: 22212895 Low-dose Taxotere Enhances the Ability of Sorafenib to Induce Apoptosis in Gastric Cancer Models Journal of Cellular and Molecular Medicine. Feb, 2011 | Pubmed ID: 20015197 À la recherche de pilote Pathways of acquis une résistance à la thérapie ciblée : génération sous-clone résistantes aux médicaments et sensibilité restauration par gène précipitation Chiara Arienti1, Sara Pignatta1, Michele Zanoni1, Michela Cortesi1, Alice Zamagni1, Filippo Piccinini2, Anna Tesei1 1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 2Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 56583 Recherche en cancérologie
À la recherche de pilote Pathways of acquis une résistance à la thérapie ciblée : génération sous-clone résistantes aux médicaments et sensibilité restauration par gène précipitation Chiara Arienti1, Sara Pignatta1, Michele Zanoni1, Michela Cortesi1, Alice Zamagni1, Filippo Piccinini2, Anna Tesei1 1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 2Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 56583 Recherche en cancérologie
